Our findings demonstrate that alterations in TTN expression are associated with various forms of cardiomyopathy, including DCM, HCM, and PPCM, characterized by a notable downregulation of TTN expression in DCM patients (Figure 1A–C). This evidence concerns the gene TTN and familial dilated cardiomyopathy.